Biolidics Limited

Equities

8YY

SGXE89830751

Advanced Medical Equipment & Technology

Market Closed - Singapore S.E. 02:45:00 2024-03-28 am EDT 5-day change 1st Jan Change
0.012 SGD 0.00% Intraday chart for Biolidics Limited +9.09% -14.29%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Biolidics to Issue Shares Worth Over SG$360,000 to New Director MT
Biolidics Limited Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Biolidics Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Biolidics Limited Announces the Change of its Registered Office Address CI
Biolidics Issues Over 87 Million Shares to Sponsor, Investor MT
Biolidics Obtains Bourse's Nod to List Over 87 Million Shares MT
Biolidics to Issue SG$50,000 of Shares to Sponsor as Partial Payment of Professional Fee MT
Biolidics to Raise Over SG$1 Million from Share Placement MT
Biolidics Ropes in Evolve Capital Advisory as Sponsor MT
Biolidics Limited Appoints Zhu Hua as A Non-Executive Non-Independent Director CI
Clearbridge Health Receives Full Amount of Outstanding Debt from Biolidics MT
Biolidics Issues 98.5 Million Shares Under Subscription Agreement; Shares Jump 8% MT
Biolidics Obtains Regulatory Nod to List 98.5 Million Shares Under Subscription Agreement MT
Biolidics Limited Announces Board Changes CI
Singapore Stocks End Week in Red; Noel Gifts Zooms 38% as Collective Sale of 50 Playfair Road Singapore Closes MT
Clearbridge Health Unit, Biolidics Sign Deal for Partial Debt Settlement MT
Biolidics to Raise Over SG$1 Million in Share Subscription Agreement MT
Biolidics Requests Trading Halt Pending News MT
Biolidics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Biolidics Signs Agreement to Raise SG$1.5 Million from Share Placement MT
Singapore Stocks Loses Further Ground Tracking Global Losses; Datapulse Technology Slips 3% as Takeover Offer Closes MT
Biolidics to Raise SG$1.5 Million from Share Placement; Shares Jump 8% MT
Biolidics Loses United Overseas Bank as Sponsor; Shares Climb 8% MT
Biolidics' Non-Executive Chairman Resigns MT
Biolidics Limited Announces Resignation of Gavin Mark Mcintyre as Independent Director and Non-Executive Independent Chairman, Chairman of the AC and Member of the NC and the RC CI
Chart Biolidics Limited
More charts
Biolidics Limited is a Singapore-based precision medicine medical technology company. The principal activities of the Company are technology development, technology transfer, marketing, selling and distribution of biomedical technology, life and medicine science related products and services; provision of laboratory services; and investment holding. It has three segments: cancer diagnostics, infectious diseases and laboratory services. Cancer diagnostics segment develops and commercializes the ClearCell FX1 System, a fully automated CE-IVD medical device which, separate and enrich cancer cells from blood, allows users of the system to perform liquid biopsies. Infectious diseases segment develops, markets and/or distributes certified test kits with various diagnostic partners. Laboratory services segment offers a range of tests. The laboratory has a regulatory approval from Singapore's Ministry of Health for molecular microbiology testing and PCR testing services for COVID-19 in Singapo
More about the company

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Biolidics Limited - Singapore S.E.
  4. News Biolidics Limited
  5. Biolidics : Surges 24% on Gaining Distribution Access in Indonesia, Deal with Chinese Biotech Company